Anticancer immune reactivity and long-term survival after treatment of metastatic ovarian cancer with dendritic cells
about
Antigen-specific active immunotherapy for ovarian cancerTherapeutic DC vaccination with IL-2 as a consolidation therapy for ovarian cancer patients: a phase I/II trial.Effects of poly (ADP-ribosyl) polymerase (PARP) inhibitor on cisplatin resistance & proliferation of the ovarian cancer C13* cellsGene Electrotransfer: A Mechanistic Perspective.
P2860
Anticancer immune reactivity and long-term survival after treatment of metastatic ovarian cancer with dendritic cells
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Anticancer immune reactivity a ...... an cancer with dendritic cells
@ast
Anticancer immune reactivity a ...... an cancer with dendritic cells
@en
type
label
Anticancer immune reactivity a ...... an cancer with dendritic cells
@ast
Anticancer immune reactivity a ...... an cancer with dendritic cells
@en
prefLabel
Anticancer immune reactivity a ...... an cancer with dendritic cells
@ast
Anticancer immune reactivity a ...... an cancer with dendritic cells
@en
P2093
P2860
P356
P1433
P1476
Anticancer immune reactivity a ...... an cancer with dendritic cells
@en
P2093
Aileen Riego-Javier
Enrique T Ona
Eunice R Batac
Gloria R Cristal-Luna
Josephine B Laguatan
Oscar Q Canlas
Romulo DE Villa
Samuel D Bernal
P2860
P356
10.3892/OL.2011.424
P577
2011-09-20T00:00:00Z